BACKGROUND: Prostate specific antigen (PSA) is widely used for prostate cancer screening but its levels are influenced by many non cancer-related factors. The goal of the study is to estimate the effect of genetic variants on PSA levels. METHODS: We evaluated the association of SNPs that were reported to be associated with prostate cancer risk in recent genome-wide association studies with plasma PSA levels in a Swedish study population, including 1,722 control subjects without a diagnosis of prostate cancer. RESULTS: Of the 16 SNPs analyzed in control subjects, significant associations with PSA levels (P < or = 0.05) were found for six SNPs. These six SNPs had a cumulative effect on PSA levels; the mean PSA levels in men were almost twofold increased across increasing quintile of number of PSA associated alleles, P-trend = 3.4 x 10(-14). In this Swedish study population risk allele frequencies were similar among T1c case patients (cancer detected by elevated PSA levels alone) as compared to T2 and above prostate cancer case patients. CONCLUSIONS: Results from this study may have two important clinical implications. The cumulative effect of six SNPs on PSA levels suggests genetic-specific PSA cutoff values may be used to improve the discriminatory performance of this test for prostate cancer; and the dual associations of these SNPs with PSA levels and prostate cancer risk raise a concern that some of reported prostate cancer risk-associated SNPs may be confounded by the prevalent use of PSA screening. 2008 Wiley-Liss, Inc.
BACKGROUND:Prostate specific antigen (PSA) is widely used for prostate cancer screening but its levels are influenced by many non cancer-related factors. The goal of the study is to estimate the effect of genetic variants on PSA levels. METHODS: We evaluated the association of SNPs that were reported to be associated with prostate cancer risk in recent genome-wide association studies with plasma PSA levels in a Swedish study population, including 1,722 control subjects without a diagnosis of prostate cancer. RESULTS: Of the 16 SNPs analyzed in control subjects, significant associations with PSA levels (P < or = 0.05) were found for six SNPs. These six SNPs had a cumulative effect on PSA levels; the mean PSA levels in men were almost twofold increased across increasing quintile of number of PSA associated alleles, P-trend = 3.4 x 10(-14). In this Swedish study population risk allele frequencies were similar among T1c case patients (cancer detected by elevated PSA levels alone) as compared to T2 and above prostate cancer case patients. CONCLUSIONS: Results from this study may have two important clinical implications. The cumulative effect of six SNPs on PSA levels suggests genetic-specific PSA cutoff values may be used to improve the discriminatory performance of this test for prostate cancer; and the dual associations of these SNPs with PSA levels and prostate cancer risk raise a concern that some of reported prostate cancer risk-associated SNPs may be confounded by the prevalent use of PSA screening. 2008 Wiley-Liss, Inc.
Authors: Anuradha Rao; Bao-L i Chang; Gregory Hawkins; Jennifer J Hu; Charles J Rosser; M Craig Hall; Deborah A Meyers; Jianfeng Xu; Scott D Cramer Journal: Urology Date: 2003-04 Impact factor: 2.649
Authors: Andrea Gsur; Martin Preyer; Gerald Haidinger; Thomas Zidek; Stephan Madersbacher; Georg Schatzl; Michael Marberger; Christian Vutuc; Michael Micksche Journal: Carcinogenesis Date: 2002-10 Impact factor: 4.944
Authors: Scott D Cramer; Bao-Li Chang; Anuradha Rao; Gregory A Hawkins; S Lilly Zheng; Wendy N Wade; Roger T Cooke; Leanne N Thomas; Eugene R Bleecker; William J Catalona; David A Sterling; Deborah A Meyers; Jill Ohar; Jianfeng Xu Journal: J Natl Cancer Inst Date: 2003-07-16 Impact factor: 13.506
Authors: Sarah M Troutman; Tristan M Sissung; Cheryl D Cropp; David J Venzon; Shawn D Spencer; Bamidele A Adesunloye; Xuan Huang; Fatima H Karzai; Douglas K Price; William D Figg Journal: Oncologist Date: 2012-03-01
Authors: Fang-Chi Hsu; Jielin Sun; Yi Zhu; Seong-Tae Kim; Tao Jin; Zheng Zhang; Fredrik Wiklund; A Karim Kader; S Lilly Zheng; William Isaacs; Henrik Grönberg; Jianfeng Xu Journal: Cancer Epidemiol Biomarkers Prev Date: 2010-03-23 Impact factor: 4.254
Authors: Jianfeng Xu; Jielin Sun; A Karim Kader; Sara Lindström; Fredrik Wiklund; Fang-Chi Hsu; Jan-Erik Johansson; S Lilly Zheng; Gilles Thomas; Richard B Hayes; Peter Kraft; David J Hunter; Stephen J Chanock; William B Isaacs; Henrik Grönberg Journal: Prostate Date: 2009-10-01 Impact factor: 4.104
Authors: Danyelle A Winchester; Cathee Till; Phyllis J Goodman; Catherine M Tangen; Regina M Santella; Teresa L Johnson-Pais; Robin J Leach; Jianfeng Xu; S Lilly Zheng; Ian M Thompson; M Scott Lucia; Scott M Lippmann; Howard L Parnes; Paul J Dluzniewski; William B Isaacs; Angelo M De Marzo; Charles G Drake; Elizabeth A Platz Journal: Prostate Date: 2015-06-05 Impact factor: 4.104
Authors: Jiyoung Ahn; Adam S Kibel; Jong Y Park; Timothy R Rebbeck; Hanna Rennert; Janet L Stanford; Elaine A Ostrander; Stephen Chanock; Ming-Hsi Wang; Rama D Mittal; William B Isaacs; Elizabeth A Platz; Richard B Hayes Journal: Clin Cancer Res Date: 2011-02-22 Impact factor: 12.531
Authors: Julius Gudmundsson; Soren Besenbacher; Patrick Sulem; Daniel F Gudbjartsson; Isleifur Olafsson; Sturla Arinbjarnarson; Bjarni A Agnarsson; Kristrun R Benediktsdottir; Helgi J Isaksson; Jelena P Kostic; Sigurjon A Gudjonsson; Simon N Stacey; Arnaldur Gylfason; Asgeir Sigurdsson; Hilma Holm; Unnur S Bjornsdottir; Gudmundur I Eyjolfsson; Sebastian Navarrete; Fernando Fuertes; Maria D Garcia-Prats; Eduardo Polo; Ionel A Checherita; Mariana Jinga; Paula Badea; Katja K Aben; Jack A Schalken; Inge M van Oort; Fred C Sweep; Brian T Helfand; Michael Davis; Jenny L Donovan; Freddie C Hamdy; Kristleifur Kristjansson; Jeffrey R Gulcher; Gisli Masson; Augustine Kong; William J Catalona; Jose I Mayordomo; Gudmundur Geirsson; Gudmundur V Einarsson; Rosa B Barkardottir; Eirikur Jonsson; Viorel Jinga; Dana Mates; Lambertus A Kiemeney; David E Neal; Unnur Thorsteinsdottir; Thorunn Rafnar; Kari Stefansson Journal: Sci Transl Med Date: 2010-12-15 Impact factor: 17.956
Authors: Kathryn L Penney; Fredrick R Schumacher; Peter Kraft; Lorelei A Mucci; Howard D Sesso; Jing Ma; Yuxin Niu; Jit Kong Cheong; David J Hunter; Meir J Stampfer; Stephen I Hsu Journal: Carcinogenesis Date: 2011-03-18 Impact factor: 4.944
Authors: Danyelle A Winchester; Bora Gurel; Cathee Till; Phyllis J Goodman; Catherine M Tangen; Regina M Santella; Teresa L Johnson-Pais; Robin J Leach; Ian M Thompson; Jianfeng Xu; S Lilly Zheng; M Scott Lucia; Scott M Lippman; Howard L Parnes; William B Isaacs; Charles G Drake; Angelo M De Marzo; Elizabeth A Platz Journal: Prostate Date: 2016-01-15 Impact factor: 4.104